Jon Read
AstraZeneca (United Kingdom)(GB)AstraZeneca (Singapore)(SG)AstraZeneca (Switzerland)(CH)AstraZeneca (Poland)(PL)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Cancer therapeutics and mechanisms, Cytokine Signaling Pathways and Interactions, Protein Kinase Regulation and GTPase Signaling, Myeloproliferative Neoplasms: Diagnosis and Treatment
Most-Cited Works
- → Structural basis for altered activity of M‐ and H‐isozyme forms of human lactate dehydrogenase(2001)335 cited
- → EED-Targeted PROTACs Degrade EED, EZH2, and SUZ12 in the PRC2 Complex(2019)194 cited
- → Phosphorylation of AMPK by upstream kinases is required for activity in mammalian cells(2017)177 cited
- Mutations of the microsomal triglyceride-transfer-protein gene in abetalipoproteinemia.(1995)
- → Identification and Activity of a Series of Azole-based Compounds with Lactate Dehydrogenase-directed Anti-malarial Activity(2004)142 cited
- → Mechanism and In Vitro Pharmacology of TAK1 Inhibition by (5Z)-7-Oxozeaenol(2012)142 cited
- →